Yahoo Web Search

Search results

  1. dionresearch.github.io › hotelling › presentationshotelling_presentation slides

    Francois Dion (fdion@dionresearch.com) is the founder and Chief Data Scientist at Dion Research, creator of visu.ai, SeekEx & SeekErr, open source software such as Stemgraphic, Signethic & Hotelling and contributor to PandasGui, Plotly, Yellowbrick & more.

  2. Nov 5, 2019 · Having built HPC solutions and data infrastructures for several companies over the years, the following recently caught my attention: <Articles that exist>. Fault tolerance in Spark applications that streamline our mature data pipelines (50 Petabytes) <Articles I wish there were more of>.

    • Who is Dion research?1
    • Who is Dion research?2
    • Who is Dion research?3
    • Who is Dion research?4
    • Who is Dion research?5
  3. May 7, 2017 · All are considered core to operations research (with an overlap of applied math, probability and statistics). If this field is completely alien to you, here's some reading material (some could arguably be found in other sections of this document):

  4. Apr 2, 2017 · Francois Dion - Recent readings. abstract: I will cover some of the essential books for data science in a 6 part series. After an overview, this one covers data and databases. (also available: Part II: model, Part III: technology, Part IV: code, Part V: visualization and part VI: communication)

    • Who is Dion research?1
    • Who is Dion research?2
    • Who is Dion research?3
    • Who is Dion research?4
    • Who is Dion research?5
  5. Aug 15, 2024 · In the wake of Céline Dion's diagnosis and comeback, stiff-person syndrome researchers and advocates march toward a cure. Céline Dion stands alone as a singer, a chart-topping ballad-belter who...

  6. Prof Vincent Dion, a Canadian researcher now based at the UK DRI at Cardiff, is an expert in DNA repair and has been studying expanded repeat diseases like Huntington’s for over a decade.

  7. People also ask

  8. Prof Vincent Dion is aiming to develop effective new treatments for trinucleotide repeat disorders. He is adapting the use of sophisticated gene-editing technologies to reduce the length of the repeat sequence and developing new techniques that can switch off the faulty gene in cells.